Biogen Statistics
Total Valuation
Biogen has a market cap or net worth of MXN 373.52 billion. The enterprise value is 450.55 billion.
Market Cap | 373.52B |
Enterprise Value | 450.55B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 146.53M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.21% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 146.16M |
Valuation Ratios
The trailing PE ratio is 12.35 and the forward PE ratio is 8.53.
PE Ratio | 12.35 |
Forward PE | 8.53 |
PS Ratio | 1.86 |
PB Ratio | 1.08 |
P/TBV Ratio | 19.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.35, with an EV/FCF ratio of 9.05.
EV / Earnings | 14.90 |
EV / Sales | 2.40 |
EV / EBITDA | 7.35 |
EV / EBIT | 9.92 |
EV / FCF | 9.05 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.39.
Current Ratio | 1.44 |
Quick Ratio | 0.87 |
Debt / Equity | 0.39 |
Debt / EBITDA | 2.07 |
Debt / FCF | 2.72 |
Interest Coverage | 9.84 |
Financial Efficiency
Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 6.48%.
Return on Equity (ROE) | 9.19% |
Return on Assets (ROA) | 5.43% |
Return on Invested Capital (ROIC) | 6.48% |
Return on Capital Employed (ROCE) | 10.43% |
Revenue Per Employee | 26.38M |
Profits Per Employee | 3.98M |
Employee Count | 7,605 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.00 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.35% in the last 52 weeks. The beta is 0.15, so Biogen's price volatility has been lower than the market average.
Beta (5Y) | 0.15 |
52-Week Price Change | -31.35% |
50-Day Moving Average | 3,407.14 |
200-Day Moving Average | 4,488.16 |
Relative Strength Index (RSI) | 31.96 |
Average Volume (20 Days) | 150 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, Biogen had revenue of MXN 200.64 billion and earned 30.24 billion in profits. Earnings per share was 206.75.
Revenue | 200.64B |
Gross Profit | 151.78B |
Operating Income | 48.48B |
Pretax Income | 35.82B |
Net Income | 30.24B |
EBITDA | 62.97B |
EBIT | 48.48B |
Earnings Per Share (EPS) | 206.75 |
Balance Sheet
The company has 53.11 billion in cash and 135.33 billion in debt, giving a net cash position of -82.22 billion.
Cash & Cash Equivalents | 53.11B |
Total Debt | 135.33B |
Net Cash | -82.22B |
Net Cash Per Share | n/a |
Equity (Book Value) | 347.03B |
Book Value Per Share | 2,368.78 |
Working Capital | 47.59B |
Cash Flow
In the last 12 months, operating cash flow was 52.77 billion and capital expenditures -2.96 billion, giving a free cash flow of 49.80 billion.
Operating Cash Flow | 52.77B |
Capital Expenditures | -2.96B |
Free Cash Flow | 49.80B |
FCF Per Share | n/a |
Margins
Gross margin is 75.65%, with operating and profit margins of 24.16% and 15.07%.
Gross Margin | 75.65% |
Operating Margin | 24.16% |
Pretax Margin | 17.85% |
Profit Margin | 15.07% |
EBITDA Margin | 31.39% |
EBIT Margin | 24.16% |
FCF Margin | 24.82% |
Dividends & Yields
Biogen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.21% |
Shareholder Yield | -0.21% |
Earnings Yield | 8.09% |
FCF Yield | 13.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Biogen has an Altman Z-Score of 3.17.
Altman Z-Score | 3.17 |
Piotroski F-Score | n/a |